Latest Biotech News

Researchers at Keck Medicine of USC demonstrated that Tumor Treating Fields (TTFields), which use alternating electric fields, combined with immunotherapy and chemotherapy, enhance T-cell...

A biomedical research team at Stony Brook University developed TRACE, a Tunable Rapid Assembly of Collagenous Elements method, enabling instant assembly and 3D bioprinting of physiological...

Researchers unveiled a novel test using solid-state nanopores and machine learning to rapidly detect viral infections by analyzing unique electrical signals as viruses pass through nanoscale...

Indiana University School of Medicine led the development of the first blood test approved by the FDA to detect amyloid plaques in the brain, a hallmark of Alzheimer's disease. The test offers a...

Alamar Biosciences partnered with the Alzheimer’s Disease Data Initiative and Gates Ventures to create a comprehensive plasma proteome atlas for Alzheimer’s and related dementias. The...

Northwestern University researchers developed an AI-driven generative model capable of resolving gene combination patterns underlying complex diseases like diabetes and cancer, surpassing...

The FDA granted approval to Merck's monoclonal antibody drug Enflonsia for preventing respiratory syncytial virus (RSV) infections in infants under 12 months. The drug is priced competitively...

Metsera reported encouraging phase I data for its long-acting amylin analogue MET-233i, indicating dose-dependent weight loss efficacy and potential for once-monthly dosing. The therapy exhibited...

Merck announced successful outcomes from two phase III studies evaluating its oral PCSK9 inhibitor, enlicitide decanoate, in patients with high cholesterol on statin therapy. The drug demonstrated...

Recursion Pharmaceuticals disclosed a 20% reduction in workforce following a recent decision to narrow its research focus and deprioritize multiple clinical-stage programs. This downsizing...

Merck received FDA approval for its RSV antibody drug, Enflonsia, targeting infants under 12 months and directly competing with Sanofi and AstraZeneca’s Beyfortus. The approval occurs amid a...

Biotech firms navigate financial turbulence and strategic deals amid sector-wide shifts. Recursion Pharmaceuticals announced 20% workforce layoffs linked to clinical pipeline cuts after merging...

Innovations span diagnostics and treatment modalities, including AI-powered rapid viral detection via nanopore technology, promising faster clinical decisions. Linear Diagnostics secured £1M UK...

The biotech community faces mounting challenges from politicization and funding cuts. Researchers issued the Bethesda Declaration urging restoration of NIH grants delayed or terminated under the...

Multiple studies illuminate neurodegenerative disease mechanisms and diagnosis. Dr. Sophia Shi detailed how sugar molecule degradation in the brain’s glycocalyx contributes to aging and...

Researchers at Stony Brook University developed TRACE (Tunable Rapid Assembly of Collagenous Elements), a novel collagen bioprinting method enabling instant assembly of physiological collagen...

Recent studies advance cancer care with novel diagnostic and therapeutic approaches. Indiana University secured FDA clearance for the first blood test detecting Alzheimer’s amyloid pathology,...

Biotech and academic researchers harness artificial intelligence to unravel genetic networks and streamline drug discovery. Northwestern University developed TWAVE, an AI tool identifying gene...

Metsera Inc. released early clinical data indicating their long-acting amylin analogue, MET-233i, induces significant dose-dependent weight loss with an extended half-life supporting once-monthly...

Merck & Co. reported positive results from two Phase III trials of their oral PCSK9 inhibitor enlicitide decanoate, achieving statistically significant reductions in LDL cholesterol in patients...